Target Name: GIMAP7
NCBI ID: G168537
Review Report on GIMAP7 Target / Biomarker Content of Review Report on GIMAP7 Target / Biomarker
GIMAP7
Other Name(s): GTPase IMAP family member 7 | immune-associated nucleotide-binding protein 7 | IAN7 | immunity-associated nucleotide 7 protein | GTPase, IMAP family member 7 | immune associated nucleotide | hIAN7 | MGC27027 | IAN-7 | Immune associated nucleotide | GIMA7_HUMAN | Immunity-associated nucleotide 7 protein

GIMAP7: A Potential Drug Target and Biomarker

GIMAP7 (Guanosine-Inositol Monophosphate Kinase 7) is a protein that is expressed in various tissues and cells in the human body. It is a member of the PI3K/Akt signaling pathway, which is a critical pathway involved in many cellular processes, including cell signaling, cell survival, and cell growth. GIMAP7 has been identified as a potential drug target and biomarker for several diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

GIMAP7 is a 21-kDa protein that is expressed in various tissues and cells, including brain, heart, liver, and muscle. It is a critical component of the PI3K/Akt signaling pathway, which is a complex protein-protein interaction that plays a central role in many cellular processes. The PI3K/Akt signaling pathway is involved in many cellular processes, including cell signaling, cell survival, and cell growth.

GIMAP7 is involved in the regulation of many cellular processes that are critical for human health and disease. For example, GIMAP7 is involved in the regulation of cell signaling, which is involved in the regulation of many cellular processes that are critical for human health and disease. For example, GIMAP7 is involved in the regulation of cell signaling, which is involved in the regulation of many cellular processes that are critical for human health and disease.

GIMAP7 is also involved in the regulation of cell survival, which is critical for the survival of many cellular processes that are critical for human health and disease. For example, GIMAP7 is involved in the regulation of cell survival, which is critical for the survival of many cellular processes that are critical for human health and disease.

GIMAP7 is also involved in the regulation of cell growth, which is critical for the growth and development of many cellular processes that are critical for human health and disease. For example, GIMAP7 is involved in the regulation of cell growth, which is critical for the growth and development of many cellular processes that are critical for human health and disease.

GIMAP7 is a potential drug target and biomarker for several diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. For example, GIMAP7 has been shown to be involved in the regulation of cancer cell growth and survival, which makes it a potential drug target for cancer. Additionally, GIMAP7 has been shown to be involved in the regulation of neurodegenerative diseases, which makes it a potential biomarker for neurodegenerative diseases. Furthermore, GIMAP7 has been shown to be involved in the regulation of autoimmune disorders, which makes it a potential drug target for autoimmune disorders.

In conclusion, GIMAP7 is a protein that is involved in the regulation of many cellular processes that are critical for human health and disease. It is a potential drug target and biomarker for several diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Further research is needed to fully understand the role of GIMAP7 in cellular processes and to develop effective treatments for these diseases.

Protein Name: GTPase, IMAP Family Member 7

Functions: The dimer has GTPase activity; the active site contains residues from both subunits

The "GIMAP7 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about GIMAP7 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

GIMAP8 | GIMD1 | GIN1 | GINM1 | GINS complex | GINS1 | GINS2 | GINS3 | GINS4 | GIP | GIPC1 | GIPC2 | GIPC3 | GIPR | GIT1 | GIT2 | GJA1 | GJA10 | GJA1P1 | GJA3 | GJA4 | GJA5 | GJA8 | GJA9 | GJA9-MYCBP | GJB1 | GJB2 | GJB3 | GJB4 | GJB5 | GJB6 | GJB7 | GJC1 | GJC2 | GJC3 | GJD2 | GJD3 | GJD4 | GK | GK2 | GK3 | GK5 | GKAP1 | GKN1 | GKN2 | GKN3P | GLA | GLB1 | GLB1L | GLB1L2 | GLB1L3 | GLC1C | GLCCI1 | GLCCI1-DT | GLCE | GLDC | GLDN | GLE1 | GLG1 | GLI1 | GLI2 | GLI3 | GLI4 | GLIDR | GLIPR1 | GLIPR1L1 | GLIPR1L2 | GLIPR2 | GLIS1 | GLIS2 | GLIS3 | GLIS3-AS1 | GLMN | GLMP | GLO1 | GLOD4 | GLOD5 | GLP1R | GLP2R | GLRA1 | GLRA2 | GLRA3 | GLRA4 | GLRB | GLRX | GLRX2 | GLRX3 | GLRX3P2 | GLRX5 | GLS | GLS2 | GLT1D1 | GLT6D1 | GLT8D1 | GLT8D2 | GLTP | GLTPD2 | Glucagon-like peptide receptor (GLP-R) | Glucosidase | GLUD1